4//SEC Filing
RINGO WILLIAM R 4
Accession 0001209191-22-017684
CIK 0001829802other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 6:24 PM ET
Size
9.4 KB
Accession
0001209191-22-017684
Insider Transaction Report
Form 4
RINGO WILLIAM R
Director
Transactions
- Award
Common Stock
2022-03-08+10,000→ 18,933 total - Award
Stock Option (Right to Buy)
2022-03-08+29,100→ 29,100 totalExercise: $3.08Exp: 2032-03-07→ Common Stock (29,100 underlying) - Award
Common Stock
2022-03-08+8,933→ 8,933 total
Footnotes (4)
- [F1]These shares represent restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in three equal annual installments on each of March 8, 2023, March 8, 2024, and March 8, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- [F2]These shares represent RSUs. Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, on March 8, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- [F3]Includes 8,933 shares acquired by the Reporting Person as of March 8, 2022 as an RSU award.
- [F4]The shares subject to the option vest monthly over thirty-six (36) months from the vesting commencement date, March 8, 2022, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
Related Parties
1- filerCIK 0001238325
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 6:24 PM ET
- Size
- 9.4 KB